Bild - 3 Februari 2024

cris-trung-3wK7RLRAAkA-unsplash_aviapharma_landingpage-qj7uiwo7cyjal8ag8kydvsn338wmo96z2gi19upjgw.jpeg

Licens: Medieanvändning
Innehållet får laddas ner, användas och delas i olika mediekanaler av t.ex. journalister, bloggare, krönikörer, opinionsbildare etc., i syftet att förmedla, redogöra för och kommentera ert pressmeddelande, inlägg eller information, så länge innehållet används oförändrat och i dess helhet. Upphovsmannen ska anges i den omfattning och på det sätt god sed kräver (vilket bl.a. innebär att fotografer till bilder nästan alltid måste anges).
Filformat: .webp
Storlek: 720 x 328, 19,5 KB

Ladda ner

Ämnen

Regioner

Kontakter

Jacob Calmvik

Presskontakt VD Affärsutveckling, förvärv, bolagsövergripande frågor jacob.calmvik@aviapharma.se 070-3707169

Marie Wikman

Presskontakt Nordisk affärsområdeschef OTC, medicinteknik, kosttillskott marie.wikman@aviapharma.se 0708168816

Mattias Wik

Presskontakt Nordisk affärsområdeschef RX mattias.wik@aviapharma.se +46 706 657675

Avia Pharma welcomes Impilo as a new partner

During January, Avia Pharma welcomed Impilo AB as a new owner and partner to the co-founders. Impilo is a Nordic investment company focused on long-term investments in sustainable healthcare companies. The partnership with Impilo will allow Avia to execute on its strategy and ambition of building a leading Northern European OTC / Rx platform through organic and inorganic growth.

Avia is a leading Swedish OTC/Rx distribution company with presence in the Nordics and Germany.

We work in the most important field there is – health. Health is fundamental in order to experience and enjoy all aspects of life. It is with this strong conviction that our company was founded in 2016 by senior executives from the pharmaceutical and pharmacy industry. Since our inception, we have experienced rapid growth, surpassing 40 million EUR in sales in 2022. Our operations nowadays span across Northern Europe, with offices in Stockholm, Helsinki, and Munich, having a focus on five therapy areas: women’s health, urology, dermatology, allergy and general OTC. Currently, our portfolio comprises more than 30 products, a combination of our own as well as licensed pharmaceuticals from international companies such as Cosette, Perrigo, Dr. Pfleger, and Menarini. Nevertheless, a greater share of sales comes from our own products.